Inventor
PRIEN OLAF
DE14 patents
⚠️ This page may combine multiple inventors who share the name “PRIEN OLAF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER SCHERING PHARMA AG
8 patentsUS7291624B2Nov 6, 2007
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
BAYER SCHERING PHARMA AG16 citations92
US7750000B2Jul 6, 2010
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
BAYER SCHERING PHARMA AG24 citations88
US7598260B2Oct 6, 2009
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
BAYER SCHERING PHARMA AG13 citations83
US7511059B2Mar 31, 2009
Thiazolidinones, their production and use as pharmaceutical agents
BAYER SCHERING PHARMA AG14 citations82
US7825128B2Nov 2, 2010
Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
BAYER SCHERING PHARMA AG7 citations60
US8003787B2Aug 23, 2011
Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
BAYER SCHERING PHARMA AG0 citations40
US7598263B2Oct 6, 2009
Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
BAYER SCHERING PHARMA AG0 citations40
US7741333B2Jun 22, 2010
Quinazoline derivatives, their preparation, their use, and medicaments comprising them
BAYER SCHERING PHARMA AG0 citations37
SCHERING AG
3 patentsUS7235561B2Jun 26, 2007
Compound and a composition including such a compound
SCHERING AG58 citations95
US7288547B2Oct 30, 2007
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
SCHERING AG54 citations92
US6747046B2Jun 8, 2004
Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents
SCHERING AG1 citations49